Holen Sie sich die Stockscreener-App
4.87
2.01%
-0.10
Handel nachbörslich:
4.87
Schlusskurs vom Vortag:
$4.97
Offen:
$4.95
24-Stunden-Volumen:
1.80M
Relative Volume:
1.60
Marktkapitalisierung:
$263.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-54.19M
KGV:
-1.8876
EPS:
-2.58
Netto-Cashflow:
$-37.34M
1W Leistung:
-6.35%
1M Leistung:
-0.61%
6M Leistung:
-29.32%
1J Leistung:
-7.41%
1-Tages-Spanne:
$4.765
$4.985
1-Wochen-Bereich:
$4.765
$5.175
52-Wochen-Spanne:
$3.9328
$7.5401
Abeona Therapeutics Inc Stock (ABEO) Company Profile
Firmenname
Abeona Therapeutics Inc
Sektor
Branche
Telefon
646-813-4701
Adresse
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
Compare ABEO vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABEO
Abeona Therapeutics Inc
|
4.87 | 269.33M | 0 | -54.19M | -37.34M | -2.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.14 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-03-05 | Eingeleitet | Oppenheimer | Outperform |
| 2024-07-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-30 | Eingeleitet | Stifel | Buy |
| 2020-11-11 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2020-09-18 | Eingeleitet | B. Riley FBR | Buy |
| 2020-02-10 | Eingeleitet | SVB Leerink | Outperform |
| 2019-12-10 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2019-08-15 | Herabstufung | Maxim Group | Buy → Hold |
| 2019-08-12 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2019-07-26 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-06-27 | Eingeleitet | Mizuho | Buy |
| 2018-10-12 | Eingeleitet | Mizuho | Buy |
| 2018-06-05 | Eingeleitet | Seaport Global Securities | Buy |
| 2017-11-08 | Eingeleitet | SunTrust | Buy |
| 2017-10-16 | Bestätigt | H.C. Wainwright | Buy |
| 2017-10-11 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-10-10 | Eingeleitet | Citigroup | Buy |
| 2017-10-05 | Bestätigt | Maxim Group | Buy |
| 2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2017-07-18 | Bestätigt | Maxim Group | Buy |
| 2017-06-22 | Fortgesetzt | Jefferies | Buy |
| 2017-01-06 | Eingeleitet | Jefferies | Buy |
| 2016-09-29 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Abeona Therapeutics Inc Aktie (ABEO) Neueste Nachrichten
Abeona Therapeutics Announces Date of Fourth Quarter, Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference - marketscreener.com
Abeona Therapeutics Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference - Bitget
Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference - marketscreener.com
Abeona Therapeutics® Announces Date of Fourth Quarter / - GlobeNewswire
Avoiding Lag: Real-Time Signals in (ABEO) Movement - Stock Traders Daily
Abeona Therapeutics Inc. $ABEO Shares Sold by Western Standard LLC - MarketBeat
Abeona Therapeutics Inc. (ABEO) Stock Analysis: Exploring a Potential 289% Upside in Gene Therapy Innovations - DirectorsTalk Interviews
Abeona Therapeutics (NASDAQ:ABEO) Stock Passes Above 50-Day Moving AverageHere's What Happened - MarketBeat
ABEO Should I Buy - Intellectia AI
Analysts Are Bullish on These Healthcare Stocks: Vanda (VNDA), Abeona Therapeutics (ABEO) - The Globe and Mail
Is Abeona Therapeutics Inc. a strong growth stockInflation Watch & Safe Entry Momentum Tips - mfd.ru
Big Picture: Does Abeona Therapeutics Inc have strong EBITDA marginsJuly 2025 EndofMonth & Safe Entry Zone Tips - baoquankhu1.vn
Discipline and Rules-Based Execution in ABEO Response - Stock Traders Daily
Abeona Therapeutics Inc. (NASDAQ:ABEO) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Epidermolysis Bullosa Clinical Trial Pipeline Robust as 20+ - openPR.com
Is Abeona Therapeutics Inc. (PCJ) stock undervalued by metricsJuly 2025 Price Swings & Low Drawdown Trading Strategies - mfd.ru
Published on: 2026-02-14 07:33:27 - mfd.ru
ABEO SEC FilingsAbeona Therapeut 10-K, 10-Q, 8-K Forms - Stock Titan
Is Abeona Therapeutics Inc. stock overvalued or fairly priced2025 Buyback Activity & Fast Moving Stock Watchlists - mfd.ru
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Seven new Abeona hires get 3-year stock grants as inducement - Stock Titan
Behavioral Patterns of ABEO and Institutional Flows - Stock Traders Daily
Abeona Therapeutics Inc. (ABEO) Investor Outlook: Unpacking A 306% Potential Upside - DirectorsTalk Interviews
Abeona Therapeutics (NASDAQ:ABEO) Director Sells 20,070 Shares - MarketBeat
Abeona sells Rare Pediatric Disease PRV for $155M - MSN
Crombez Eric sells Abeona Therapeutics (ABEO) shares for $82895 By Investing.com - Investing.com Nigeria
Abeona Therapeutics director sells $75k in stock By Investing.com - Investing.com South Africa
Crombez Eric sells Abeona Therapeutics (ABEO) shares for $82895 - Investing.com
Abeona Therapeutics director sells $75k in stock - Investing.com
Abeona Therapeutics (NASDAQ:ABEO) Director Eric Crombez Sells 16,284 Shares - MarketBeat
Abeona Therapeutics (NASDAQ:ABEO) Director Mark Alvino Sells 2,000 Shares - MarketBeat
Leila Alland Sells 18,065 Shares of Abeona Therapeutics (NASDAQ:ABEO) Stock - MarketBeat
Insider-Favored Growth Companies To Watch February 2026 - simplywall.st
Multiple Abeona Therapeutics Directors Quietly Unload Significant Blocks of Stock - TipRanks
Merger Talk: Is Abeona Therapeutics Inc in a bullish channelSwing Trade & Stock Timing and Entry Methods - baoquankhu1.vn
Sentiment Watch: How does FVNNU score in quality rankingsBond Market & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Dividend Watch: How does CBTJ correlate with NasdaqWeekly Gains Summary & Accurate Buy Signal Notifications - baoquankhu1.vn
Is Abeona Therapeutics Inc. stock forming a cup and handleJuly 2025 Highlights & Reliable Volume Spike Alerts - mfd.ru
Abeona Therapeutics Inc. (ABEO) Stock Analysis: Exploring a 327% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
(ABEO) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Abeona Therapeutics (NASDAQ:ABEO) Insider Madhav Vasanthavada Sells 12,610 Shares of Stock - MarketBeat
Abeona Therapeutics Inc. (NASDAQ:ABEO) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Abeona Therapeutics CEO Seshadri Vishwas sells $372k in shares By Investing.com - Investing.com India
Abeona Therapeutics CFO Vazzano sells $99k in shares By Investing.com - Investing.com Australia
Abeona Therapeutics (NASDAQ:ABEO) CEO Sells $372,204.56 in Stock - MarketBeat
Joseph Walter Vazzano Sells 18,666 Shares of Abeona Therapeutics (NASDAQ:ABEO) Stock - MarketBeat
Abeona Therapeutics CFO Vazzano sells $99k in shares - Investing.com
O’Malley, Abeona Therapeutics SVP, sells $72k in stock By Investing.com - Investing.com South Africa
O’Malley, Abeona Therapeutics SVP, sells $72k in stock - Investing.com
Finanzdaten der Abeona Therapeutics Inc-Aktie (ABEO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Abeona Therapeutics Inc-Aktie (ABEO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Silverstein Christine Berni | Director |
Feb 02 '26 |
Sale |
5.09 |
20,070 |
102,168 |
137,722 |
| Wuchterl Donald A. | Director |
Feb 02 '26 |
Sale |
5.09 |
14,814 |
75,412 |
167,935 |
| Crombez Eric | Director |
Feb 02 '26 |
Sale |
5.09 |
16,284 |
82,895 |
63,456 |
3.69%
0.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):